Hjem › Mantelcellelymfom › Washington › Seattle
Mantelcellelymfom kliniske forsøg i Seattle, WA
12 studier for Mantelcellelymfom søger deltagere på steder i og omkring Seattle (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.
RekruttererFase 1/2
- Research Site, Seattle
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
RekruttererFase 1/2
- Fred Hutchinson Cancer Research Center, Seattle
A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.
RekruttererFase 1/2
- Fred Hutchinson Cancer Research Center, Seattle
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
RekruttererFase 1
- Swedish Cancer Institute (SCI), Seattle
This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma
RekruttererFase 1
- Fred Hutchinson Cancer Center, Seattle
DALY II USA/ MB-CART2019.1 for DLBCL
RekruttererFase 2
- Fred Hutchinson Cancer Center, Seattle
Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies
RekruttererFase 2Frivillige med god helbredstilstand velkomne
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Sonrotoclax, Rituximab, and Zanubrutinib in Treating Participants With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, and Mantle Cell Lymphoma
RekruttererFase 2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Study of SGR-1505 in Mature B-Cell Neoplasms
RekruttererFase 1
- Fred Hutchinson Cancer Center, Seattle
BAFFR-targeting CAR T Cells for Patients With Relapsed or Refractory B-NHL
RekruttererFase 1
- Providence Swedish Cancer Institute, Seattle
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservationsstudie
- Massive Bio SYNERGY-AI site, Seattle
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
RekruttererFase 1
- Swedish Cancer Institute, Seattle
Mantelcellelymfom forsøg i andre byer
- Baldwin Park, CA15 studier
- Houston, TX15 studier
- Durham, NC13 studier
- New York City, NY12 studier
- Milwaukee, WI12 studier
- Boston, MA11 studier
- Columbus, OH11 studier
- Nashville, TN11 studier
- Chicago, IL10 studier
- Portland, OR9 studier
- Rochester, MN9 studier
- St. Louis, MO8 studier
Andre studier i Seattle
- Ikke-småcellet lungecancer53 studier
- Kræft (alle typer)49 studier
- Prostatakræft42 studier
- Akut myeloid leukæmi40 studier
- Brystkræft39 studier
- Metastatisk cancer39 studier
- Colorektal kræft34 studier
- Lungecancer33 studier
- Ægstockræft30 studier
- Multipelt myelom22 studier
- Myelodysplastiske syndromer21 studier
- Akut lymfoblastisk leukæmi21 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.